claim: thromboembolic events and apparent heparin resistance in patients infected with sars-cov-2
evidence_1: antifactor xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin.", "thota r, ganti ak, subbiah s. apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor viii levels.")